Try our beta test site

A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Neurotech Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00447993
First received: March 9, 2007
Last updated: November 15, 2016
Last verified: November 2016